Lobbying

Baudax Bio's latest lobbying report covers Q1 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Baudax Bio

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Baudax Bio lobbying by quarter
Baudax Bio lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$01
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$30K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
BGR Government Affairs$30K2 quarters

Former officials lobbying for it

Former position
BRENT ALAN DEL MONTESee prior filingQ4 2022
DANIEL FARMERSee prior filingQ4 2022
JOHN STONESee prior filingQ4 2022
REMY LEIGH BRIM MASONSee prior filingQ4 2022

Lobbying reports

Filed by
23/03/08for Q1 2023BGR Government AffairsUnder $5,000
23/01/20for Q4 2022BGR Government Affairs$30K